| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 07/17/2008 | CA2672307A1 Bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| 07/16/2008 | EP1944305A1 Quinoline derivatives as phosphodiesterase inhibitors |
| 07/16/2008 | EP1944300A2 Prodrugs of aspartyl protease inhibitors |
| 07/16/2008 | EP1944030A1 Agent for treatment of schizophrenia |
| 07/16/2008 | EP1944024A1 O-substituted aniline derivative and antioxidant drug |
| 07/16/2008 | EP1943247A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 07/16/2008 | EP1943234A1 Triazole compounds as lipoxygenase inhibitors |
| 07/16/2008 | EP1943223A1 9-amino-acridine derivatives and their use for eliminating misfolded proteins |
| 07/16/2008 | EP1943222A1 Antibacterial active 5-chinolin derivative |
| 07/16/2008 | EP1943221A1 Piperazine amidines as antiviral agents |
| 07/16/2008 | EP1942905A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/16/2008 | EP1583532B1 Quinoline derivatives as glucokinase ligands |
| 07/16/2008 | EP1527049B1 Fused heterocyclic compounds as peptidase inhibitors |
| 07/16/2008 | EP1476151B1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders |
| 07/16/2008 | EP1386913B1 Pyrrole derivative |
| 07/16/2008 | EP1286966B1 4-aminopiperidine derivatives and their use as medicine |
| 07/16/2008 | EP1073654B1 2,3-olefinic epothilone derivatives |
| 07/16/2008 | EP1054004B1 Novel pyrimidine-5-carboxamide derivatives |
| 07/16/2008 | CN101223166A Thiazolyl MGLUR5 antagonists and methods for their use |
| 07/16/2008 | CN101223157A Methods for synthesizing heterocyclic compounds |
| 07/16/2008 | CN101223155A Benzoheterocyclylethylcarboxamide derivatives |
| 07/16/2008 | CN101223147A Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 07/16/2008 | CN101223140A Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 07/16/2008 | CN101222924A Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 07/16/2008 | CN101220024A A set of anti-cancer compound restraining kinase |
| 07/16/2008 | CN100402525C Pyridine derivatives as fungicidal compounds |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/16/2008 | CN100402032C Tetrahydroquinoline analogues as muscarinic agonists |
| 07/15/2008 | US7399866 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 07/15/2008 | US7399865 such as (E)-N-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide used as antineoplastic agents, or inhibitors of the HER-2 gene or proteins and epidermal growth factor receptor enzymes |
| 07/15/2008 | US7399781 N-substituted benzothiophenesulfonamide derivatives |
| 07/15/2008 | US7399780 pyridin-2-yl-1H-indole or pyrimidin-4-yl-1H-indole derivatives; enzyme inhibitor of glycogen synthase kinase-3; treating dementia, Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis, corticobasal degeneration, Down syndrome, Huntington's Disease |
| 07/15/2008 | US7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists |
| 07/15/2008 | US7399771 Piperidine derivatives as CCR5 inhibitors |
| 07/15/2008 | US7399767 Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 07/15/2008 | US7399765 Substituted diazabicycloalkane derivatives |
| 07/15/2008 | US7399759 1, 3-benzothiazinone derivatives and use thereof |
| 07/15/2008 | US7399749 For therapy and prophylaxis of disorders associated with the HCV protease |
| 07/15/2008 | CA2480583C Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
| 07/15/2008 | CA2421120C Quinolinone derivatives as tyrosine kinase inhibitors |
| 07/10/2008 | WO2008083356A1 Substituted triazoles useful as axl inhibitors |
| 07/10/2008 | WO2008083238A2 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
| 07/10/2008 | WO2008082487A2 Novel jnk inhibitors |
| 07/10/2008 | WO2008081399A2 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 07/10/2008 | WO2008080965A2 Hiv inhibiting 5,6-substituted pyrimidines |
| 07/10/2008 | WO2008080964A1 Hiv inhibiting 6-substituted pyrimidines |
| 07/10/2008 | WO2008080938A1 Use 2-substituted pyridines for cancer treatment |
| 07/10/2008 | WO2008080511A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 07/10/2008 | WO2008048991A3 Organic compounds |
| 07/10/2008 | WO2008010921A3 Modulators of pharmacokinetic properties of therapeutics |
| 07/10/2008 | WO2007064553A3 Thiazole derivatives as cxcr3 receptor modulators |
| 07/10/2008 | US20080167318 Pharmaceutically active pyrrolidine derivatives |
| 07/10/2008 | US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders |
| 07/10/2008 | US20080167303 Aryl sulfamide derivatives and methods of their use |
| 07/10/2008 | US20080167301 Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as Pde4 Inhibitors |
| 07/10/2008 | US20080166362 New effector conjugates, process for their production and their pharmaceutical use |
| 07/10/2008 | CA2710051A1 Substituted triazoles useful as axl inhibitors |
| 07/10/2008 | CA2674185A1 Hiv inhibiting 5,6-substituted pyrimidines |
| 07/10/2008 | CA2674178A1 Hiv inhibiting 6-substituted pyrimidines |
| 07/10/2008 | CA2672940A1 Novel jnk inhibitors |
| 07/10/2008 | CA2669821A1 2-aza-bicyclo[3.1.0]hexane derivatives |
| 07/09/2008 | EP1942104A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 07/09/2008 | EP1942101A1 Secretase inhibitor |
| 07/09/2008 | EP1940829A2 Imidazole derivatives and their use for modulating the gabaa receptor complex |
| 07/09/2008 | EP1940827A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/09/2008 | EP1940826A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/09/2008 | EP1940825A1 Quinazoline derivatives as anticancer agents |
| 07/09/2008 | EP1940805A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 07/09/2008 | EP1940787A1 Novel ido inhibitors and methods of use thereof |
| 07/09/2008 | EP1940786A1 Biphenyl derivatives and their use in treating hepatitis c |
| 07/09/2008 | EP1940516A2 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 07/09/2008 | EP1786808B1 Method for the preparation of rosiglitazone |
| 07/09/2008 | EP1768978B1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 07/09/2008 | EP1653957B1 Piperidine compounds useful as malonyl-coa decarboxylase inhibitors |
| 07/09/2008 | EP1583762B1 Pyrrolyl-thiazoles and their use as cb 1 receptor inverse agonists |
| 07/09/2008 | EP1465863B1 Potassium channel modulators |
| 07/09/2008 | EP1332133B1 Metabotropic glutamate receptor antagonists |
| 07/09/2008 | EP1303490B1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 07/09/2008 | EP1220842B1 Cyclic amine compound as ccr5 antagonist |
| 07/09/2008 | CN101218237A Oxime derivative and preparations thereof |
| 07/09/2008 | CN101218236A 2-heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 07/09/2008 | CN101218235A Bicyclic derivatives as modulators of ion channels |
| 07/09/2008 | CN101218232A Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 07/09/2008 | CN101218226A Bicyclic derivatives as modulators of ion channels |
| 07/09/2008 | CN101217954A Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 07/09/2008 | CN101215270A Fluorine-containing benzothiazole sulphuryl compounds and its preparation and application |
| 07/09/2008 | CN100400519C N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 07/09/2008 | CN100400518C Phthalazinone derivatives |
| 07/09/2008 | CN100400041C Diaminothiazoles used as CDK4 inhibitors |
| 07/09/2008 | CN100400040C Tripeptidyl peptidase inhibitors |
| 07/08/2008 | WO2008083353A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/08/2008 | US7396929 Synthesis of 3-amino-4-substituted pyrazole derivatives |
| 07/08/2008 | US7396848 oxazole derivatives to treat diabetic neuropathy and/or other kinds of peripheral neuropathy; 4-(4-chlorophenyl)-5-[3-(2-methoxyphenoxy)propyl]-2-(2-methyl-1-imidazolyl)oxazole |
| 07/08/2008 | US7396842 Five-membered cyclic compounds |
| 07/08/2008 | US7396840 Chemokine receptor binding heterocyclic compounds |
| 07/08/2008 | US7396838 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally |
| 07/08/2008 | US7396832 Inhibitors of Akt activity |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/08/2008 | US7396830 Piperazine amidines as antiviral agents |
| 07/08/2008 | US7396829 such as 2H-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-[5-(nitrooxy)pentyl]-, 1,1-dioxide; contains at least one nitric oxide enhancing group; excessive water or electrolyte retention conditions; cardiovascular diseases, and diseases resulting from oxidative or endothelial dysfunctions |